Stock Screener App

Frei -

Installieren

1.75

0.53% -0.00

after-market

Handel nachbörslich: 1.74 -0.01 -0.57%

Iovance Biotherapeutics Inc (IOVA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IOVA? Forum Prognose Aktiensplit

Iovance Biotherapeutics Inc Aktie (IOVA) Neueste Nachrichten

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance - Bluefield Daily Telegraph

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesIOVA - FinancialContent

The Gross Law Firm Notifies Shareholders of Iovance Biotherapeutics, Inc. (IOVA) of a Class ... - Bluefield Daily Telegraph

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - FinancialContent

Wealth Enhancement Advisory Services LLC Lowers Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World

Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks And Legal PressureHagens Berman - ACCESS Newswire

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK - Bluefield Daily Telegraph

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER - GlobeNewswire

Iovance Biotherapeutics CFO Jean-Marc Bellemin to Depart - MarketScreener

ROSEN, A LEADING LAW FIRM, Encourages Iovance - GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc.IOVA - PR Newswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was - GlobeNewswire

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - PR Newswire

IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Contact Levi & Korsinsky Before July 14, 2025 to Join Class Action - ACCESS Newswire

Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) should contact The Gross Law Firm about pending Class ActionIOVA - PR Newswire

Shareholders of Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights Before July 14, 2025 – Contact Levi & Korsinsky - ACCESS Newswire

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance ... - Eagle-Tribune

Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance Biotherapeutics, Inc.(IOVA) Shareholders - GlobeNewswire Inc.

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Shareholders of Class Action Lawsuit and July 14, 2025 Deadline - ACCESS Newswire

Iovance Biotherapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationIOVA - The Victoria Advocate

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance - GlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA - TradingView

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - StreetInsider

Iovance: Amtagvi's Rocky Launch And Mounting Concerns Lead To A 'Sell' Rating - Seeking Alpha

IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA) - GlobeNewswire

iovance cfo resigns to pursue new opportunities By Investing.com - Investing.com India

iovance cfo resigns to pursue new opportunities - Investing.com

Iovance Biotherapeutics IncJean-Marc Bellemin To Resign As CFO - marketscreener.com

Iovance Biotherapeutics’ SWOT analysis: TIL therapy stock faces challenges amid promise - Investing.com India

Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA)Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire

Shareholders of Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

Investors who lost money on Iovance Biotherapeutics, Inc. (IOVA) should contact Levi & ... - Bluefield Daily Telegraph

Investors who lost money on Iovance Biotherapeutics, Inc. - GlobeNewswire

Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire

IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit - marketscreener.com

Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman - GlobeNewswire

IOVA CLASS ACTION: Invest in Iovance Biotherapeutics, Inc.? - GlobeNewswire

Levi & Korsinsky Urges Iovance Biotherapeutics, Inc. (IOVA) Shareholders to Act Before Lead Plaintiff Deadline July 14, 2025 - ACCESS Newswire

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - GlobeNewswire

IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor LawsuitHagens Berman - ACCESS Newswire

Iovance Biotherapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross ... - Bluefield Daily Telegraph

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - The Victoria Advocate

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER - GlobeNewswire

Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA) – Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS ... - Bluefield Daily Telegraph

Transcript : Iovance Biotherapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 01 - marketscreener.com

IOVA LEGAL NOTICE: Lose Money when Iovance Biotherapeutics, - GlobeNewswire

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK ... - Bluefield Daily Telegraph

Iovance Biotherapeutics, Inc. (IOVA) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire

Investors of Iovance Biotherapeutics, Inc. (IOVA) Have Until July 14, 2025 To Seek a Leadership Role In The Class Action LawsuitContact Kaplan Fox - FinancialContent

GMAB

$20.30

0.29%

RPRX

$36.37

0.22%

SMMT

$24.55

7.43%

INSM

$97.80

3.83%

BNTX

$110.00

1.61%

ONC

$245.49

0.48%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters